Given the huge and growing GLP-1 weight loss market, recent trial data from Viking Therapeutics could make it a potential acquisition target for a larger concern.While many bigger pharma names might ...
Source LinkGiven the huge and growing GLP-1 weight loss market, recent trial data from Viking Therapeutics could make it a potential acquisition target for a larger concern.While many bigger pharma names might ...
Source Link
Comments